Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
VY ›
VYDURA
Trademark search for:
VYDURA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2022-07-08 — Application filed
2022-07-12 — Application filed
2022-07-13 — Application filed
2022-10-27 — Attorney/dom.rep.revoked and/or appointed
2022-10-27 — Teas change of owner address received
2022-10-27 — Teas change of correspondence received
2022-10-27 — Applicant/correspondence changes (non-responsive) entered
2022-10-27 — Teas revoke/app/change addr of atty/dom rep received
2022-12-07 — Assigned to examiner
2022-12-08 — Suspension letter written
2022-12-08 — Notification of letter of suspension e-mailed
2022-12-08 — Letter of suspension e-mailed
2023-05-03 — Attorney/dom.rep.revoked and/or appointed
2023-05-03 — Teas withdrawal as domestic representative received
2023-05-03 — Teas change of correspondence received
2023-05-03 — Teas withdrawal of attorney received
2023-05-03 — Teas revoke/app/change addr of atty/dom rep received
2023-05-03 — Withdrawal of attorney granted
2023-05-04 — Attorney/dom.rep.revoked and/or appointed
2023-05-04 — Teas change of correspondence received
2023-05-04 — Teas revoke/app/change addr of atty/dom rep received
2023-06-07 — Approved for pub - principal register
2023-06-21 — Notification of notice of publication e-mailed
2023-07-11 — Published for opposition
2023-07-11 — Official gazette publication confirmation e-mailed
2023-09-05 — Noa e-mailed - sou required from applicant
2024-02-12 — Sou teas extension received
2024-02-12 — Sou extension 1 filed
2024-02-12 — Sou extension 1 granted
2024-02-13 — Notice of approval of extension request e-mailed
2024-10-07 — Application abandoned
2024-10-07 — Application abandoned
2024-10-07 — Final status recorded
Owner Information
Biohaven Pharmaceutical Ireland DAC
Ringaskiddy IE
Biohaven Pharmaceutical Ireland DAC
Ringaskiddy IE
Correspondent
Andrea Christensen Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192 United States
Filing Details
Filing Date:
2022-07-08
Status Date:
2024-10-07
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.